IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 1 filers reported holding IVERIC BIO INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $11,248,565 | +124.1% | 285,932 | +38.6% | 0.01% | +120.0% |
Q1 2023 | $5,020,155 | -71.2% | 206,336 | -74.6% | 0.01% | -73.7% |
Q4 2022 | $17,405,623 | +1020.8% | 812,967 | +838.9% | 0.02% | +850.0% |
Q3 2022 | $1,553,000 | +748.6% | 86,589 | +354.2% | 0.00% | – |
Q2 2022 | $183,000 | -97.1% | 19,063 | -94.9% | 0.00% | -100.0% |
Q4 2021 | $6,216,000 | +5400.9% | 371,728 | +2172.9% | 0.01% | – |
Q4 2020 | $113,000 | -33.1% | 16,355 | -45.5% | 0.00% | – |
Q3 2020 | $169,000 | -89.3% | 30,020 | -90.3% | 0.00% | -100.0% |
Q2 2020 | $1,575,000 | -10.1% | 308,802 | -39.3% | 0.00% | -33.3% |
Q1 2020 | $1,751,000 | -68.2% | 509,031 | -20.7% | 0.00% | -50.0% |
Q4 2019 | $5,505,000 | +621.5% | 641,588 | -5.9% | 0.01% | +500.0% |
Q3 2019 | $763,000 | -13.9% | 681,661 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $886,000 | – | 681,661 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 2,583,786 | $8,888,000 | 9.40% |
Soleus Capital Management, L.P. | 1,607,153 | $5,529,000 | 6.43% |
Burrage Capital Management LLC | 1,521,382 | $4,990,000 | 4.91% |
VR Adviser, LLC | 2,586,537 | $8,898,000 | 2.41% |
Samsara BioCapital, LLC | 862,552 | $2,967,000 | 1.71% |
Tamarack Advisers, LP | 1,250,000 | $4,300,000 | 1.63% |
Consonance Capital Management LP | 3,150,565 | $10,838,000 | 0.81% |
Ghost Tree Capital, LLC | 828,459 | $2,850,000 | 0.76% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,267,409 | $7,800,000 | 0.25% |
ACUTA CAPITAL PARTNERS, LLC | 139,000 | $478,000 | 0.23% |